-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA STAFF REVIEWERS FLAG CONCERNS REGARDING REPLIMUNE'S CANCER DRUG TRIAL AHEAD OF JULY 30 ADVISORY COMMITTEE MEETING - BRIEFING DOCS

Reuters·07/28/2026 11:41:06

Please log in to view news